Purdue Pharma Cuts More Than Half of U.S. Sales Staff Amid Opioid Crisis Post author:Sam Post published:February 12, 2018 Post category:BioPharma That announcement is a big change in the way Purdue has aggressively marketed OxyContin in the past. Source: BioSpace You Might Also Like Here Are 5 Tricky Job Interview Questions You Might Get at Genentech, Regeneron, and Stratos February 15, 2017 Massachusetts??? Homology Medicines Snags $83.5M to Advance AMEnDR into Human Trials July 31, 2017 Argentum And Eli Lilly Settle Patent Dispute Over CIALIS August 22, 2017
Here Are 5 Tricky Job Interview Questions You Might Get at Genentech, Regeneron, and Stratos February 15, 2017